Skip to main content

DIADEMA PARTNERS LP

Position in RLAY — Relay Therapeutics, Inc.

CIK 2026172 MORRISTOWN, NJ

Position in RLAY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,315,966
+$4,088,291 QoQ
Shares Held
230,677
+428.9% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
1.63%
of 13F equity value
Holder Rank
#82
of 256 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RLAY Over Time

Shares Held

Position Value (USD)

Derivatives in RLAY

reported options exposure · as of Mar 31, 2025
CallValue
$344,268
CallShares
131,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DIADEMA PARTNERS LP holds $217,374,297 across 66 Biotechnology names. RLAY ranks #12 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RLAY

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,315,966 230,677
2025-09-30 $227,675 43,616
2025-06-30 $150,911 43,616
2025-03-31 $1,117,026 426,346
2025-03-31 $344,268 131,400
2024-12-31 $2,083,805 505,778
2024-12-31 $412,000 100,000